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INTRODUCTION
Feline immunodeficiency virus (FIV)
was first isolated in 1986 from a group of
cats in California that were exhibiting
signs of an immunodeficiency syndrome27.
It has subsequently been classified as a
lentivirus in the Retroviridae family based
on morphology and genome organisa-
tion23,26. Human immunodeficiency virus
(HIV) is also a member of the genus
Lentivirus and both viruses behave simi-
larly in their respective hosts2. Therefore,
FIV is becoming an increasingly useful
small animal model in understanding
HIV infection, particularly in the devel-
opment of vaccines and therapeutic
agents.
In domestic cats, seroepidemiological
surveys have revealed a worldwide distri-
bution of FIV with variable prevalence. In
some regions of the United States, FIV
prevalence is less than 2 % of the healthy
cat population whilst in Japan FIV is
found in up to 12 % of healthy cats11,41. The
same surveys recorded prevalences in
sick cats of 14 % and 44 %, respectively.
South Africa could be considered to have
a relatively high FIV seroprevalence with
a recent study finding that 22.2 %
(101/454) of sick domestic cats were FIV
antibody positive33. The variation in prev-
alence is likely to reflect the different
systems of cat management throughout
the world. Since FIV is spread via saliva
during biting, the increased prevalence
in certain countries is thought to be asso-
ciated with cats being allowed to roam
more freely between indoors and out-
doors, with a consequent increase in
territorial fighting28.
Lentiviruses are characteristically un-
stable viruses with genetic variants con-
stantly evolving due to the high error rate
of the viral polymerase enzyme during
DNA synthesis2. The complete genome
sequence of FIV was first reported in
198923,36 and subsequent sequence com-
parisons have revealed high levels of
heterogeneity of the envelope (env) gene
sequence in particular. Nine distinct
variable regions (V1–V9), interspersed by
more conserved domains, have been
identified within the FIV env gene24.
Based on sequence differences in the
variable V3–V5 region of the env gene, FIV
has been divided into 5 subtypes (desig-
nated A, B, C, D, and E)8,20. Nucleotide
sequence divergence among subtypes is
17.8–38.0 %, whereas intra-subtype dif-
ferences are 2.5–15.0 %4,34.
Worldwide, subtypes A and B are the
most prevalent subtypes and have a
relatively wide geographical distribution
in comparison with subtypes C, D and E.
Subtypes A and B have been found in the
United States, Canada, Europe, Australia
and Japan1,13,21,34. Subtype C has been
identified predominantly in Canada,
Vietnam and Taiwan1,19,39. Subtypes D and
E have a more limited distribution,
having been isolated only in Japan and
Argentina, respectively20,25.
The extensive genetic diversity of FIV
has been a major obstacle in the develop-
ment of a successful vaccine5,40. In 2002,
a dual subtype FIV vaccine became
commercially available (Fel-O-Vax FIV®,
Fort Dodge Animal Health). This vaccine
contains inactivated infected cells and
whole viruses from subtypes A and D. In
addition to providing protection against
homologous subtypes, this vaccine has
been shown to be protective against
subtype B challenge16,29,30. Vaccinated cats
developed broad-spectrum humoral and
cellular immunity30.
Identifying the type and diversity of
FIV strains is essential, not only to mini-
mise the chance of vaccine breakdown
in regions where vaccination is to be
implemented but it will also assist in the
development of molecular based diag-
nostic assays. Currently, vaccinated and
infected cats cannot be distinguished
because diagnostic tests rely on the detec-
tion of FIV antibodies18. Therefore, new
assays based on viral nucleic acid or anti-
gen detection will become increasingly
important as they directly detect compo-
nents of the virus. However, the accu-
racy of some of these diagnostic tests
may be affected by variability in the target
sequence, and therefore an understand-
ing of subtype variation is required.
The prevailing FIV subtype(s) present
in the South African domestic cat popula-
tion is unknown. Preliminary data from a
worldwide survey were based on only 2
naturally infected South African cats whose
FIV clustered with subtype A isolates1.
This was based on an indirect measure of
variability, a heteroduplex mobility assay
on PCR fragments encompassing the
V3–V4 region of the env gene. In this
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study, we present sequence diversity data
of the V3–V5 region of the FIV env gene
from domestic cats in South Africa.
MATERIALS AND METHODS
Viral samples
Thirty-three blood samples from South
Africa were sent to the Veterinary Virology
Laboratory, University of Queensland,
Australia. All samples were collected from
FIV positive cats, based on antibody de-
tection by the ELISA method (FeLV
antigen/FIV antibody Snap Combo Plus,
IDEXX Laboratories). The samples origi-
nated from cats presented to the Onder-
stepoort Veterinary Academic Hospital in
Pretoria, private veterinary practices in
Durban and Cape Town, and a cat rescue
centre in Johannesburg. The cats were
bled from either the jugular or cephalic
veins and blood was drawn into heparin
tubes. The samples required gamma
irradiation (an Australian Quarantine
and Inspection Service requirement)
before handling in Australia. Before the
samples were received, 2 Australian
samples collected during a similar survey
underwent a ‘trial’ irradiation to ensure
that the PCR was not adversely affected
by the irradiation procedure. The 2 samples
were successfully amplified following the
50 k Gray irradiation.
DNA extraction
Genomic DNA was extracted from
200 µ of whole blood using the Wizard®
SV Genomic DNA Purification System
(Promega), according to the manufac-
turer’s instructions. The genomic DNA
was eluted in a total volume of 250 µ
nuclease-free water and stored in aliquots
at –20 °C until use.
The genomic DNA of 4 samples was
extracted using the BioRobot® EZ1 Work-
station and EZ1 DNA blood cards (Qiagen)
following manufacturer’s protocols. This
system utilises magnetic beads to bind
DNA.
Polymerase chain reaction (PCR)
The V3–V5 region of the env gene was
amplified in 2 overlapping fragments
using the primer pairs su3-su4 and
su5-su6. Primers su3-su4 amplify the
region between nucleotides 7314 and
7806 of the published Petaluma sequence
(GenBank accession number M25381)
and the primer pair su5-su6 amplify from
nucleotides 7660 to 794223. Primer se-
quences are as follows:
su3 5’ ATWCCAAAATGTGGATGGTGG 3’
su4 5’ AATAAGGTCATCTACCTTCAT 3’
su5 5’ AATCCTGTAGATTGTACCATG 3’
su6 5’ TCCTGCYACTGGRTTATACCA 3’
PCR amplification was performed in a
reaction mixture (12.5 µ ) containing 2
mM MgCl2, 200 µM of each deoxy-
nucleoside triphosphate, 0.8 µM of each
primer and 1 unit Expand High Fidelity
Enzyme mix (Roche®). Reaction condi-
tions were an initial denaturation at 94 °C
for 1 minute, followed by 40 cycles of
denaturation at 94 °C for 1 minute, anneal-
ing at 55 °C for 1 minute and extension at
72 °C for 1 minute. This was followed by a
final extension at 72 °C for 10 minutes.
For some products, 2 rounds of PCR
were performed. The band of the appro-
priate size was excised from an agarose
gel and gel purified followed by sodium
acetate and isopropanol precipitation and
used to reseed a PCR with conditions as
described above, with the exception of
1.5 mM MgCl2 and an annealing tempera-
ture of 60 °C in a 30 cycle PCR program.
Sequencing
PCR amplified fragments were purified
using the MinElute™ PCR Purification Kit
(Qiagen) and directly sequenced using
the Big Dye Terminator Cycle Sequencing
Kit (v3.1) (Applied Biosystems) using
both forward and reverse PCR primers or
using 1 primer at least twice. Full length
(V3–V5) sequences were deduced from
alignment of the overlapping fragments.
Owing to poor sample quality, 6 samples
(Ca10, Jo6, Pr4, Pr5, Pr6, and Pr8) could be
sequenced for the shorter su5-su6 frag-
ment only and 1 sample (Ca6) could be
sequenced for the su3-su4 fragment only.
Two samples from Johannesburg were
excluded from the analysis as they could
not be amplified.
Sequence and phylogenetic analysis
Multiple sequence alignments were
created with ClustalW37 aligning the
sequences  in  this  study  with  up  to  38
previously reported sequences outlined
in the caption of Fig. 1. Amino acid se-
quences were compared to evaluate the
conservation of amino acid sites such as
cysteine residues and N l inked
glycosylation sites. Phylogenetic and mo-
lecular evolutionary analyses were con-
ducted using MEGA version 3.115. Genetic
distances between pairs of sequences
were determined using the Kimura
2-parameter model14. An unrooted neigh-
bour joining tree32 was constructed to de-
termine the phylogenetic relationships. In
each instance, bootstrap analysis7 was
performed with 1000 repetitions to evalu-
ate clade consistency. Information on the
direction of evolutionary change could
not be deduced as there is no outgroup se-
quence. Phylogenetic trees were gener-
ated using full length sequences and
sequences obtained from the individual
fragments (5’ su3-su4 and 3’ su5-su6).
RESULTS
Sequence analysis
Up to 682 nucleotides, representing
the V3–V5 region of the env gene were
sequenced from 31 blood samples of FIV
infected cats from 4 regions of South
Africa (GenBank accession numbers
DQ873700-DQ873733). Sequences of
this whole region (in 2 overlapping
fragments) were achieved for 24 samples
while only the 3’ su5-su6 region was able
to be sequenced for 6 samples and for 1
sample only the 5’ su3-su4 region was
successfully amplified and sequenced.
Comparisons of the predicted amino acid
sequences with representatives from each
of the subtypes confirmed that the targeted
region  was  sequenced.  In  concordance
with previous reports, cysteine residues
and N-linked glycosylation sites were
relatively well conserved, which reflects
their functional importance to the enve-
lope glycoprotein (data not shown)12,20,25.
Phylogenetic analysis
Analysis of pairwise genetic distances is
indicative of the presence of 2 sub-
types within South Africa with pairwise
genetic distances of up to 38.1 % observed
with the su5-su6 sequences, whereas the
su3-su4 sequences showed a maximum
pairwise genetic distance of 14.8 %4,12.
In order to classify the sequences from
this study into the appropriate subtypes,
neighbour joining phylogenetic trees
were constructed with sequences repre-
sentative of each of the subtypes. Phylo-
genetic analyses showed that the
majority of South African sequences
clustered within subtype A (Fig. 1). In
Fig. 1 (a) samples were excluded from the
phylogenetic analysis if only 1 fragment
was amplified or if inconsistencies in sub-
type assignment between the 2 fragments
were observed. For these sequences, sepa-
rate phylogenetic analyses of the su3-su4
and su5-su6 fragments were performed.
The su3-su4 fragments (25 samples) clus-
tered within subtype A. The su5-su6 frag-
ments clustered either within subtype A
or subtype C (Fig. 1 b).
For the majority of samples, phylogenetic
grouping of sequences of the individual
fragments was consistent with respect to
subtype classification when analysed
separately. However, for 3 samples (Pr9,
Ca11, Ca12), an inconsistency with sub-
type assignment was noted when the
different fragments were subjected to
phylogenetic analysis. The 5’ fragments,
amplified with the primers su3-su4,
clustered within subtype A while the 3’
fragments, amplified with the primers
su5-su6, grouped with other subtype C
viruses confirming the presence of 2 sub-
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types, A and C, in domestic cats in South
Africa.
In this study, isolates within South
Africa did not cluster by geographical
region, with sequences from each region
distributed throughout the tree. The
South African A and C isolates did not
cluster separately from the other A or C
isolates from other regions of the world.
However, bootstrap values are generally
quite low within the subtypes, and there-
fore a definitive association between sub-
type and geographical location cannot be
made.
Subtype relationship to clinical
disease
The cats in this study showed clinical
signs that are often associated with FIV
infection and these are summarised in
Table 1. Only the 4 feral cats sampled from
Johannesburg were considered to be free
of clinical disease. A wide variety of clini-
cal signs was reported, the most common
being anorexia and weight loss. Other
common presenting signs were pyrexia,
lethargy, inflammation of the mouth, skin
disease, haematological disorders, neo-
plasia, hepatic and respiratory disease.
No obvious relationship of subtype to
clinical disease was apparent.
DISCUSSION
This preliminary study demonstrates
the presence of FIV subtypes A and C in
the domestic cat population of South
Africa, with subtype A the most prevalent.
The presence of subtype A had previously
been suggested based on heteroduplex
mobility analysis utilising the V3–V4
region of the env gene of the virus from
only 2 cats from South Africa1.
Sequences were generated for 2 over-
lapping fragments encompassing the
V3–V5 region of the env gene. For most
samples, (21/24), the individual fragments
grouped consistently within subtype A
when phylogenetic analyses was per-
formed. However, 3 isolates (Ca11, Ca12,
Pr9) showed an inconsistency with subtype
assignment. It was observed that the 5’
region of these sequences (amplified by
su3-su4) most closely resembled subtype A
while the remaining downstream sequence
appeared most closely related to subtype
C. Dual infection and/or intersubtype
recombination, either within an individual
or as a PCR artefact, may explain some of
these findings. However, to definitively
confirm the presence of recombinants,
analysis of full length genomes is necessary.
The genetic diversity of lentiviruses,
including FIV, is a result of errors that
occur during replication, in addition to
recombination1,2. Superinfection and
recombination in FIV infected cats have
been demonstrated under experimental
conditions1,17,22 and as more sequence data
become available from around the world,
there is increasing evidence to support
their occurrence during natural FIV infec-
tion, particularly in areas where different
subtypes are known to exist31. Dual infec-
tion and recombination are, therefore,
theoretical possibilities in South Africa
and may explain the subtype discrepan-
cies observed with the 3 discordant
isolates.
Although many disease states are asso-
ciated with FIV, the association between
subtype and severity of disease is still
uncertain. Potential correlations between
FIV subtype and disease have been re-
ported1,3,21. Cats infected with subtypes A
or C are generally more likely to be symp-
tomatic than cats infected with sub-
type B1,20. Ikeda et al.10 also found that sub-
type A infected cats developed AIDS-
related clinical signs earlier than cats with
subtype B infection10. In the present
study, cats harboured subtype A or C
viruses and except for the 4 feral cats from
Johannesburg, all cats demonstrated
some sign of disease. The sample popula-
tion could be considered to be biased
because, apart from the feral cats, all the
sampled cats were visiting a veterinary
clinic. Nonetheless, there appeared to be
no difference in clinical status between
the cats infected with subtype C or sub-
type A in this study. In humans, several
studies investigating the relationship
between HIV subtype and pathogenicity
have been performed with varying con-
clusions9.38. It is possible that any observed
differences could be due to confounding
factors such as environmental factors
and, therefore, more studies are required
to determine whether any significant
correlation exists between subtype and
pathogenicity.
FIV isolates have been observed to
cluster according to geographical loca-
tion. Two types of geographical clustering
have been noted. Firstly, subtypes may
group by geographical location within a
country. An example of this is seen among
FIV infected cats in Japan where sub-
type B is found predominantly in eastern
regions and subtype D is found mainly in
western regions20. Secondly, the presence
of geographically localised subclusters
within a subtype has been observed. For
example, Austrian and Portugese isolates
form distinct clusters within subtype B4,35.
In the phylogenetic trees constructed
from sequences in this study, no cluster-
ing of isolates from similar geographical
regions was observed, nor did the South
African isolates form a unique cluster
within subtypes A or C. However, it is pre-
mature to infer that this is not occurring
due to the low bootstrap values observed
within subtype A in particular.
The substantial and increasing genetic
diversity of FIV has made the develop-
ment of a successful vaccine difficult.
However, the Fel-O-Vax FIV® dual sub-
type vaccine has been shown experimen-
tally to provide good protection against
homologous and heterologous subtype
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Figure 1: Unrooted neighbour joining phylogenetic trees inferred from the alignment of previously described FIV nucleotide sequences
and the sequences determined in this study using Kimura’s 2-parameter model. Bootstrap values, as a percentage of 1000 bootstrap
replicates, are shown on branches where values are greater than 50%. Branch lengths are drawn to scale. The subtypes A, B, C, D and E are
indicated. The South African isolates from this study are designated Ca for Cape Town samples, Du for Durban samples, Jo for Johannes-
burg samples and Pr for Pretoria samples and are shown in bold. The isolate name, country of origin and GenBank accession numbers for
the published sequences included in this study are:
Subtype A: Petaluma (USA) M25381, Dixon (USA) L00608, PPR (USA) M36968, USCAtt01A (USA) U02411, USCAlemy01A (USA) U02404,
DEBAb91 (Germany) AF531043, UK2 (United Kingdom) X69494, UK8 (United Kingdom) X69496, UT113 (Netherlands) X60725, DutchK1 (Nether-
lands) M73964, SwissZ2 (Switzerland) X57001, Wo (France) L06135, Sendai1 (Japan) D37813.
Subtype B:TM2 (Japan) M59418, Yokohama (Japan) D37812, Sendai2 (Japan) D37814, Aomori2 (Japan) D37817, TAU01 (Japan) AB010405, Italy
M2 (Italy) X69501, ATVIa33 (Austria) AF531045, LP9 (Argentina) D84497, FP4 (Portugal) AJ304983, TLP3 (Portugal) AJ304987.
Subtype C:FIVC (Canada) AF474246, CABCpady02C (Canada) U02392, CABCpbar07 (Canada) U02397, AlC01 (Japan) AB010396, VND-3 (Viet-
nam) AB083509, TI-4 (Taiwan) ABO16028, MU-3 (Taiwan) AB016668.
Subtype D:Shizuoka (Japan) D37811, Fukuoka (Japan) D37815, OKA01 (Japan) AB010400, KUM02 (Japan) AB010399, MY8 (Japan) D67063.
Subtype E: LP-3 (Argentina) D84496, LP-20 (Argentina) D84498, LP-24 (Argentina) D84500.
(a) Tree constructed from ‘full length’ V3–V5 env nucleotide sequence alignment.
(b) Tree constructed from su5-su6 fragment of env nucleotide sequence alignment.
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challenge16,29,30. Its efficacy in the field
had been uncertain but recent studies
designed to mimic natural conditions
have supported its efficacy against more
diverse FIV16,29. It was found to afford
good protection against a subtype B
(Aomori2) infection when vaccinated,
unvaccinated and infected cats were
mingled. Additionally, it was found to
be efficacious against a virulent in vivo
derived subtype B challenge29. However,
others have reported that the vaccine
afforded no protection against a virulent
subtype A challenge6.
It is difficult to speculate on the poten-
tial efficacy of this FIV vaccine in South
Africa. The majority of evidence suggests
that it would be beneficial in reducing
infection with subtype A viruses (which
predominate in South Africa) but its
efficacy against subtype C infection is
uncertain. The ability of the vaccine to
protect against heterologous subtype
challenge is suggestive of the develop-
ment of broad spectrum immunity. This
broad spectrum immunity may be the
consequence of utilising 2 subtypes (sub-
types A and D) within the vaccine30. It has
been speculated that using 2 subtypes may
direct the immune system to common
epitopes which could enhance vaccine
immunity across the subtypes42. Given
that the vaccine provides protection
against diverse subtype B infection, it is
possible that protection will be achieved
against other subtypes and more diverse
viral strains. However, this cannot be
confirmed until vaccine trials are per-
formed with more diverse challenges.
In conclusion, this study has found FIV
subtypes A and C in the South African
domestic cat population, with subtype A
predominant. Of interest is the finding of
a high degree of FIV genetic diversity
among infected cats in South Africa and
the detection of diverse sequences within
some individual cats. Further research is
required to fully elucidate these findings.
This knowledge assists in our under-
standing of FIV diversity which may have
implications in preventative and diagnos-
tic strategies.
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